The nuclear receptor TLX (NR2E1) inhibits growth and progression of triple-negative breast cancer
Aug 4, 2022·,,,,,,
,,·
1 min read
Adam T Nelczyk
Liqian Ma
Anasuya Das Gupta
Hashni Epa Vidana Gamage
Michael T McHenry
Madeline a Henn
Mohammed Kadiri

Yu Wang
...
Erik R Nelson

Type
Publication
Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease, 1868, 11
Publication’s full text or supplementary notes will be updated.